CS1:LSE:LSE-Amundi IBEX 35 UCITS ETF Acc GBP (GBX)

ETF | Others |

Last Closing

USD 27350

Change

-57.50 (-0.21)%

Market Cap

USD 0.10B

Volume

182.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-414.00 (-2.04%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-2.54 (-0.97%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-12.20 (-6.34%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.62 (-3.49%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.64 (-4.67%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-6.49 (-5.96%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.85 (+2.57%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-1.02 (-3.41%)

USD 259.48B
0QZO:LSE 0QZO

-6.35 (-6.50%)

USD 258.54B

ETFs Containing CS1:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.37% 94% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.37% 94% A 90% A-
Trailing 12 Months  
Capital Gain 21.54% 93% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.54% 92% A 86% B+
Trailing 5 Years  
Capital Gain 124.86% 89% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 124.86% 87% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.20% 77% C+ 77% C+
Dividend Return 14.20% 77% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.91% 58% F 75% C
Risk Adjusted Return 119.28% 96% N/A 98% N/A
Market Capitalization 0.10B 49% F 28% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.